{"disease":{"id":"hypercholesterolemia-familial","name":"hypercholesterolemia familial"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03989167","title":"Clinical Decision Support for Familial Hypercholesterolemia","phase":"NA","overall_status":"RECRUITING","enrollment_count":460000,"lead_sponsor_name":"University Hospital, Linkoeping","has_results":false},{"nct_id":"NCT04118348","title":"Evaluating the Efficacy of Pediatric Lipid Screening Alerts","phase":"NA","overall_status":"COMPLETED","enrollment_count":13340,"lead_sponsor_name":"Geisinger Clinic","has_results":true},{"nct_id":"NCT02808403","title":"Long Term Post Marketing Specified Drug Use Result Survey for Evolocumab in Japan","phase":"","overall_status":"COMPLETED","enrollment_count":6000,"lead_sponsor_name":"Amgen","has_results":false},{"nct_id":"NCT03814187","title":"Trial to Assess the Effect of Long Term Dosing of Inclisiran in Subjects With High CV Risk and Elevated LDL-C","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":3275,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT05952856","title":"A Study of Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) in Adults With Hypercholesterolemia (MK-0616-013) CORALreef Lipids","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":2912,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":false},{"nct_id":"NCT05142722","title":"Randomized Study to Evaluate the Effect of Obicetrapib on Top of Maximum Tolerated Lipid-Modifying Therapies","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":2530,"lead_sponsor_name":"NewAmsterdam Pharma","has_results":true},{"nct_id":"NCT03110432","title":"Prospective German Very High Cardiovascular Risk Patients Dyslipidemia Treatment Indication Registry","phase":"","overall_status":"COMPLETED","enrollment_count":1695,"lead_sponsor_name":"GWT-TUD GmbH","has_results":false},{"nct_id":"NCT03694197","title":"Long Term Safety Study of PRALUENT","phase":"PHASE4","overall_status":"TERMINATED","enrollment_count":1389,"lead_sponsor_name":"Regeneron Pharmaceuticals","has_results":true},{"nct_id":"NCT06005597","title":"Study of Obicetrapib & Ezetimibe Fixed Dose Combination on Top of Maximum Tolerated Lipid-Modifying Therapies","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":407,"lead_sponsor_name":"NewAmsterdam Pharma","has_results":true},{"nct_id":"NCT04370899","title":"Early Detection of Familial Hypercholesterolemia in Children","phase":"","overall_status":"RECRUITING","enrollment_count":400,"lead_sponsor_name":"Institut Investigacio Sanitaria Pere Virgili","has_results":false},{"nct_id":"NCT05261126","title":"A Study of the Efficacy and Safety of Enclitide Chloride (MK-0616 Oral PCSK9 Inhibitor) in Adults With Hypercholesterolemia (MK-0616-008)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":381,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT05425745","title":"Evaluate the Effect of Obicetrapib in Patients With HeFH on Top of Maximum Tolerated Lipid-Modifying Therapies.","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":354,"lead_sponsor_name":"NewAmsterdam Pharma","has_results":true},{"nct_id":"NCT04666298","title":"Study of Efficacy and Safety of Inclisiran in Japanese Participants With High Cardiovascular Risk and Elevated LDL-C","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":312,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT01524289","title":"Study to Assess the Tolerability and Efficacy of Anacetrapib (MK-0859) Co-Administered With Statin in Participants With Heterozygous Familial Hypercholesterolemia (MK-0859-020)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":306,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT05952869","title":"A Study of Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) in Adults With Heterozygous Familial Hypercholesterolemia (MK-0616-017/CORALreef HeFH)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":303,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT04837638","title":"Diet Quality and Coronary Artery Calcification in Adults With Heterozygous Familial Hypercholesterolemia","phase":"","overall_status":"UNKNOWN","enrollment_count":258,"lead_sponsor_name":"Laval University","has_results":false},{"nct_id":"NCT06439654","title":"Atlantic Lipid Lowering Treatment Optimization Program","phase":"NA","overall_status":"RECRUITING","enrollment_count":250,"lead_sponsor_name":"Atlantic Health System","has_results":false},{"nct_id":"NCT04526457","title":"Is Family Screening Improved by Genetic Testing of Familial Hypercholesterolemia","phase":"NA","overall_status":"COMPLETED","enrollment_count":240,"lead_sponsor_name":"University of Pennsylvania","has_results":false},{"nct_id":"NCT04656028","title":"Genetic Testing and Motivational Counseling for FH","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":180,"lead_sponsor_name":"National Medical Research Center for Therapy and Preventive Medicine","has_results":false},{"nct_id":"NCT01375751","title":"Reduction of Low-Density Lipoprotein Cholesterol (LDL-C) With PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder Study","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":168,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT02748057","title":"A Clinical Trial to Assess the Long Term Safety and Tolerability of MK-0653H in Japanese Participants With Hypercholesterolemia (MK-0653H-833)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":135,"lead_sponsor_name":"Organon and Co","has_results":true},{"nct_id":"NCT02460159","title":"A Clinical Trial to Assess the Long Term Safety and Tolerability of MK-0653C in Japanese Participants With Hypercholesterolemia (MK-0653C-384)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":135,"lead_sponsor_name":"Organon and Co","has_results":true},{"nct_id":"NCT07470723","title":"The ORIGIN-FH Study","phase":"NA","overall_status":"RECRUITING","enrollment_count":70,"lead_sponsor_name":"University of Wisconsin, Madison","has_results":false},{"nct_id":"NCT04073797","title":"PET Imaging of Inflammation and Lipid Lowering Study","phase":"NA","overall_status":"RECRUITING","enrollment_count":63,"lead_sponsor_name":"University of Cambridge","has_results":false},{"nct_id":"NCT01576484","title":"Open-Label Extension of Study R727-CL-1003 (NCT01266876) to Evaluate the Long-Term Safety and Efficacy of Alirocumab (REGN727) in Participants With Heterozygous Familial Hypercholesterolemia (HeFH)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":58,"lead_sponsor_name":"Regeneron Pharmaceuticals","has_results":true},{"nct_id":"NCT06535542","title":"Integrating Whole Genome Sequencing and Digital Twins Into the Management of Hypercholesterolemia in Emiratis","phase":"NA","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"Abu Dhabi Health Services Company","has_results":false},{"nct_id":"NCT04313270","title":"Subclinical Atherosclerosis in Patients With Familial Hypercholesterolemia Treated With Evolocumab®","phase":"","overall_status":"UNKNOWN","enrollment_count":25,"lead_sponsor_name":"Federico II University","has_results":false},{"nct_id":"NCT06231459","title":"Expression of Pro- and Anti-inflammatory Cytokines During Anti-PCSK9 in Familial Hypercholesterolemia","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado","has_results":false},{"nct_id":"NCT03795038","title":"Comparison of the Plasma Lipoprotein Apheresis Systems DIAMED and MONET vs. the Whole Blood Apheresis System DALI","phase":"NA","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Fresenius Medical Care Deutschland GmbH","has_results":false},{"nct_id":"NCT06293729","title":"Safety and Efficacy Study of NGGT006 in Refractory Hypercholesterolemia Patients","phase":"EARLY_PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":9,"lead_sponsor_name":"Suzhou Municipal Hospital","has_results":false},{"nct_id":"NCT04722068","title":"Regeneron 1331 Kinetics Sub-Study HoFH","phase":"NA","overall_status":"COMPLETED","enrollment_count":4,"lead_sponsor_name":"University of Pennsylvania","has_results":false}],"total":31},"guidelines":[],"source":"Drug Landscape verified database"}